Please login to the form below

Not currently logged in
Email:
Password:

Life

This page shows the latest Life news and features for those working in and with pharma, biotech and healthcare.

Blood disorder specialists Imara raises $63m

Blood disorder specialists Imara raises $63m

The financing was co-led by US-based OrbiMed Advisors and the Arix Bioscience, a UK life science investor, which committed $15m (£11.3m) to the company.

Latest news

More from news
Approximately 74 fully matching, plus 2,474 partially matching documents found.

Latest Intelligence

  • Bringing life to precision medicine Bringing life to precision medicine

    Harnessing the power of patient-derived organoids

  • “Brexit has been a catalyst for UK clinical research... it’s turbocharged change” “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

    Among the concrete actions taken since the Brexit referendum nearly three years ago is the creation of the UK Life Science Sector Deal. ... NIHR. While initiatives such as the Life Science Sector Deal are broad and ambitious, it’ll take many years for

  • Rare Diseases Day Rare Diseases Day

    Each of these diseases has a severe impact on everyday life for patients and carers, who need to adapt to incorporate an often complex and arduous daily care routine. ... One in 20 people will be affected by a rare disease at some point in their life,

  • Visualising medicine Visualising medicine

    This is particularly important with pharma, where mould-breaking solutions are integral to creating accessible messaging for life-changing products.

  • Combining therapies and combining research Combining therapies and combining research

    Quicker, safer, cheaper. Helperby has already established that its combination technique has the potential to extend the life of last-resort antibiotics.

More from intelligence
Approximately 19 fully matching, plus 399 partially matching documents found.

Latest appointments

More from appointments
Approximately 33 fully matching, plus 345 partially matching documents found.

Latest from PMHub

  • A Magical Future – A year on from the graduate scheme

    My “graduate life” at Lucid finished in September, when I took up the role of an Associate Medical Writer, in a new team full of new faces and new clients.

  • My adventure into the world of Medcomms and Lucid’s Futures Academy

    future. I wanted to find a role where I could make a measurable impact on someone’s life, and not have to wait 20 years to possibly see it (I could

  • Device Attribute Testing

    The patient evaluation needed to reflect real life as much as possible, so that it truly reflected patient preference and could predict the future market impact of any new device.

  • 20 questions: Round 6

    As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month we asked our employees about office life in Singapore.

  • New opportunities in emerging markets

    Until recently, multinational pharmaceutical and life sciences companies have focused their clinical research efforts/clinical development programs almost exclusively on mature markets: North America, Europe and Japan in particular.

More from PMHub
Approximately 12 fully matching, plus 579 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics